6.70% -0.026

Harvard Bioscience Inc (HBIO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Harvard Bioscience Inc Stock (HBIO) Company Profile

Harvard Bioscience Inc

Healthcare (1152)

(508) 893-8999

84 OCTOBER HILL RD, HOLLISTON, MA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

HBIO's Discussions on Twitter

Vergleichen Sie HBIO mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HBIO Harvard Bioscience Inc	0.3631	16.85M	106.79M	-8.73M	10.81M	-0.20
ISRG Intuitive Surgical Inc	466.99	175.60B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	195.06	59.07B	20.64B	1.73B	2.94B	6.02
ALC Alcon Inc	91.41	44.80B	9.91B	1.02B	665.00M	2.05
RMD Resmed Inc	209.72	31.51B	4.93B	1.25B	1.38B	8.47
COO The Cooper Companies, Inc.	78.31	15.83B	3.90B	392.30M	288.10M	1.95

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-04-09	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2023-03-10	Hochstufung	The Benchmark Company	Speculative Buy → Buy
2021-01-07	Hochstufung	The Benchmark Company	Speculative Buy → Buy
2020-12-09	Eingeleitet	Northland Capital	Outperform
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Overweight
2019-07-08	Herabstufung	Janney	Buy → Neutral
2018-01-24	Bestätigt	Janney	Buy
2018-01-23	Bestätigt	The Benchmark Company	Buy
2016-11-17	Eingeleitet	Singular Research	Buy
2015-07-28	Eingeleitet	The Benchmark Company	Buy

Alle ansehen

Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten

Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)

Harvard Bioscience Inc (HBIO)

Harvard Bioscience Inc Stock (HBIO) Company Profile

Vergleichen Sie HBIO mit anderen Aktien

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten

Harvard Bioscience’s Bertrand Loy to Step Down - TipRanks

Benchmark reiterates Harvard Bioscience stock with $4.50 target By Investing.com - Investing.com India

Harvard Bioscience’s (HBIO) Sector Weight Rating Reiterated at KeyCorp - Defense World

Harvard Bioscience (HBIO) Announces CFO Transition - GuruFocus

Harvard Bioscience Announces CFO Transition | HBIO Stock News - GuruFocus

Harvard Bioscience (HBIO) Sees CFO Transition with Interim Appoi - GuruFocus

Lacklustre Performance Is Driving Harvard Bioscience, Inc.'s (NASDAQ:HBIO) 49% Price Drop - simplywall.st

Harvard Bioscience Appoints Mark Frost as Interim CFO - citybiz

Harvard Bioscience appoints interim CFO amid market challenges By Investing.com - Investing.com Canada

Harvard Bioscience CFO Jennifer Cote Resigns - marketscreener.com

Harvard Bioscience CFO Resignation and Interim Appointment - TipRanks

Harvard Bioscience appoints interim CFO amid market challenges - Investing.com

Harvard Bioscience Announces CFO Transition - The Manila Times

KeyBanc cuts Harvard Bioscience stock rating on financing risk By Investing.com - Investing.com Canada

Estimating The Fair Value Of Harvard Bioscience, Inc. (NASDAQ:HBIO) - Yahoo Finance

KeyBanc Downgrades Harvard Bioscience to Sector Weight From Overweight, Removes $3 Price Target - marketscreener.com

KeyBanc cuts Harvard Bioscience stock rating on financing risk - Investing.com

Harvard Bioscience Slides As Insider Purchases Lose Another US$76k - simplywall.st

Harvard Bioscience (NASDAQ:HBIO) Price Target Cut to $4.50 by Analysts at Benchmark - Defense World

Harvard Bioscience at 37th Annual ROTH Conference: Strategic Growth Amid Challenges By Investing.com - Investing.com South Africa

Harvard Bioscience at 37th Annual ROTH Conference: Strategic Growth Amid Challenges - Investing.com

Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2024 Earnings Call Transcript - Insider Monkey

Harvard Bioscience Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Harvard Bioscience Inc (HBIO) Q4 2024 Earnings Call Highlights: - GuruFocus.com

Harvard Bioscience Inc (HBIO) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada

Harvard Bioscience Reports 2024 Financial Results - TipRanks

Harvard Bioscience Navigates Growth Amid Challenges - TipRanks

Harvard Bioscience secures waiver for credit covenant By Investing.com - Investing.com Australia

Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025 - GlobeNewswire

Harvard Bioscience CEO to Host Fireside Chats at Roth and KeyBanc Healthcare Forums - StockTitan

Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewswire

Earnings call transcript: Harvard Bioscience Q4 2024 beats expectations but faces market challenges - Investing.com

Harvard Bioscience Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Harvard Bioscience slumps after weak revenue forecast - TradingView

HARVARD BIOSCIENCE Earnings Results: $HBIO Reports Quarterly Earnings - Nasdaq

Harvard Bioscience reports Q4 adjusted EPS 6c vs. 4c last year - TipRanks

Harvard Bioscience earnings beat, revenue topped estimates By Investing.com - Investing.com UK

Harvard Bioscience Achieves Profit Turnaround Despite Revenue Challenges in Latest Quarter - StockTitan

Harvard Bioscience IncQ4 2024 Revenues $24.6 Million -March 12, 2025 at 07:04 am EDT - Marketscreener.com

Harvard Bioscience Q4 and Full-Year 2024 Financial Results - TradingView

Harvard Bioscience secures waiver for credit covenant - Investing.com

Harvard BioscienceExploring Alternative Capital Sources For Refinancing Outstanding Indebtedness By June 30 - Marketscreener.com

Costco Price Plunge Equals Opportunity for Investors - The Globe and Mail

Harvard Bioscience (HBIO) Expected to Announce Earnings on Wednesday - The AM Reporter

Harvard Bioscience, Inc. to Host Earnings Call - ACCESS Newswire

HBIO stock touches 52-week low at $0.86 amid market challenges - Investing.com Australia

Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie HBIO